A phase 1 trial of CD25/Treg-depleted DLI plus Ipilimumab for myeloid disease relapse after matched-HCT
NOT ENROLLING
Trial ID:
NCT03912064 Protocol # :
19-142
Phase
I
Disease Sites
Other Hematopoietic
Myeloid and Monocytic Leukemia
Principal Investigator
Koreth, John
Site Investigator
Koreth, John
Site Research Nurses
Beshere, Gianna
Brock, Jennifer
Halloran, Elizabeth
More, Avnee, P.
Trial Description
Call 877-DF-TRIAL (877-338-7425) to learn more about this clinical trial, protocol #19-142
19-142